UNSPSC 51391743: Adrenalin or adrenaline or epinephrine

This classification denotes a catecholamine and adrenergic agonist with the molecular formula C9H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YKH834O4BH, chemically known as 3,4-dihydroxy-alpha-(methylaminomethyl)benzyl alcohol but generally known as adrenaline, which bears US NIH Compound Identifier 838. Adrenaline comes in various forms, including acid tartrate, bitartrate, borate, carboxylic acid, chloride, hydrochloride, hydrogen tartrate, and sulfate.

UNSPSC 51391743 Adrenalin or adrenaline or epinephrine is a Commodity code covering pharmaceutical products, specifically injectable emergency medications. State and local procurement under this code focuses on acquisition of epinephrine-based formulations and related emergency medical supplies to support community health programs, emergency response capabilities, and public health initiatives. Issuing bodies include county health departments and state health and human services agencies. The scope of work reflects direct procurement of finished pharmaceutical products rather than raw materials or compounding services, with contracts typically structured around annual volume commitments, quarterly or regular delivery schedules, and compliance with pharmaceutical handling, storage, and chain-of-custody requirements.

Seminole County, Florida recently issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone annually through competitive bidding with a response deadline of July 26, 2023, for delivery to its Community Health Building; the contract includes a two-year initial term with one-year renewal option and requires E-Verify compliance, workers' compensation insurance, and drug-free workplace certification. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs that would include pharmaceutical procurement outside traditional pharmacy benefit manager channels, signaling potential expansion of state-level procurement mechanisms for prescription drugs including epinephrine products. Recent activity spans Florida and Texas, with Florida counties demonstrating immediate procurement needs for emergency pharmaceutical inventory and Texas exploring alternative distribution models for state-level pharmacy benefit management.